Particulars |
|
|
|
Company Name
| Piramal Pharma Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
1,329.25 |
B.V. (₹) |
56.10 |
Sales(₹ Cr.) |
5,285.71 |
NP (₹ Cr.) |
690.16 |
NP Var (%) |
78.00 |
Div% |
1.00 |
CPS(₹) |
6.90 |
EPS (₹) |
5.20 |
Traded Value(₹ Lakhs) |
449.49 |
52 Week High |
308.00 |
52 Week Low |
165.00 |
Price BSE |
191.00 |
Price NSE |
191.00 |
Market Capital (₹ Cr.) |
25,335.47 |
P/C Ratio |
27.80 |
P/E Ratio |
36.80 |
Price Vs.BV |
3.40 |
|
Latest Quarter |
Year End |
202506 |
Sales (₹ Cr.) |
969.88 |
NP(₹ Cr.) |
113.14 |
NP Var % |
33.00 |
Trailing Twelve Months |
Year End |
202506 |
Sales |
4,897.03 |
OPM |
18.78 |
NP |
642.75 |
NP Var (%) |
41.07 |
EPS |
5.41 |
PE |
35.23 |
|
|